• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一种生物反应调节剂对胸段淋巴细胞的影响——一项涉及临床病例和动物实验的研究]

[The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments].

作者信息

Hanaue H, Kurosawa T, Miyakawa S, Kitano Y, Nemoto A, Yamoto H, Asagoe T, Shikata J

出版信息

Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1285-9.

PMID:3488025
Abstract

The influence of a biological response modifier on thoracic lymphocytes was studied clinically and experimentally. The thoracic lymphocytes and peripheral blood were taken from nine cases of gastric cancer relapse before and after the administration of hemolytic streptococci, OK-432 (PIC), for immunological examination. T: B cell ratio, T cell ratio and ADCC activity of the thoracic lymphocytes and peripheral blood were not changed but the NK activities of both were increased. The juvenilization of lymphocytes was reduced but that of the peripheral blood was not changed. The number and the ratio of T cells in the thoracic lymphocytes of Wistar rats were considerably increased by the administration of PIC but they were reduced in the peripheral blood. T-cell subsets of thoracic lymphocytes and peripheral blood were hardly changed by the administration of PIC. In the case immunological treatment, the thoracic lymphocytes and blood lymphocytes should be monitored because their biological specificities are different.

摘要

临床上和实验上研究了一种生物反应调节剂对胸段淋巴细胞的影响。从9例胃癌复发患者在给予溶血链球菌OK-432(PIC)前后采集胸段淋巴细胞和外周血进行免疫学检查。胸段淋巴细胞和外周血的T:B细胞比值、T细胞比值和ADCC活性未改变,但两者的NK活性均增加。淋巴细胞的年轻化程度降低,但外周血的未改变。给予PIC后,Wistar大鼠胸段淋巴细胞中T细胞的数量和比例显著增加,但外周血中的则降低。给予PIC后,胸段淋巴细胞和外周血的T细胞亚群几乎未改变。在进行免疫治疗时,应监测胸段淋巴细胞和血液淋巴细胞,因为它们的生物学特性不同。

相似文献

1
[The influence of a biological response modifier on thoracic lymphocytes--a study involving clinical cases and animal experiments].[一种生物反应调节剂对胸段淋巴细胞的影响——一项涉及临床病例和动物实验的研究]
Gan To Kagaku Ryoho. 1986 Apr;13(4 Pt 2):1285-9.
2
Effects of biological response modifier on thoracic duct lymphocytes in recurrent gastric cancer. Evaluation of OK-432, a hemolytic streptococcus preparation.生物反应调节剂对复发性胃癌胸导管淋巴细胞的影响。溶血性链球菌制剂OK-432的评估。
Tokai J Exp Clin Med. 1987 May;12(2):97-102.
3
Effects of oral administration of streptococcal preparation OK-432 on thoracic duct lymphocytes.口服链球菌制剂OK-432对胸导管淋巴细胞的影响。
Tokai J Exp Clin Med. 1987 Sep;12(3):159-65.
4
[An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
Gan To Kagaku Ryoho. 1985 Dec;12(12):2305-13.
5
[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)].[一项通过免疫学参数评估口服溶链菌制剂(沙培林)的最佳剂量及其给药频率的双盲研究(第二篇报告)]
Nihon Gan Chiryo Gakkai Shi. 1990 May 20;25(5):997-1012.
6
[Basic studies on the effects of oral administration of streptococcal preparation OK-432. I. Effects of thoracic duct lymphocytes].
Nihon Gan Chiryo Gakkai Shi. 1987 Aug 20;22(7):1348-53.
7
[Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer].[溶链菌制剂对胃癌患者外周血单个核细胞产生淋巴因子、白细胞介素-1、白细胞介素-2及干扰素的术后活性变化的影响]
Nihon Gan Chiryo Gakkai Shi. 1987 Apr 20;22(3):603-13.
8
[Immunological study on localized liver injection of immunopotentiator OK-432-- experimental studies in rats].
Gan To Kagaku Ryoho. 1984 Oct;11(10):2267-71.
9
[Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].[溶血性链球菌制剂OK-432对复发性胃癌的治疗]
Nihon Gan Chiryo Gakkai Shi. 1987 Aug 20;22(7):1367-72.
10
Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.接受链球菌制剂OK-432免疫治疗的胃癌患者的免疫学参数
Keio J Med. 1982 Dec;31(4):159-68. doi: 10.2302/kjm.31.159.